[1]
Zou, P. et al. 2012. Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics. Journal of Pharmacy & Pharmaceutical Sciences. 15, 2 (Apr. 2012), 265–280. DOI:https://doi.org/10.18433/J34S4N.